Dergiler / GORM:Gynecology Obstetrics & Reproductive Medicine / 2005 / Cilt: 11 - Sayı: 2

Comparison of vaginal metronidazole with vaginal clindamycin for the treatment of bacterial vaginosis in women using intrauterine devices

Sayfa
107–109
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: Clindamycin 2% vaginal cream offers similar efficacy to vaginal metronidazole administration for treatment of bacterial vaginosis in women using intrauterin devices.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To examine the efficacy of clindamycin vaginal cream and vaginal metronadizole for the treatment of bacterial vaginosis in intrauterin device users.
📊
Temel Bulgular & Veri:Study Design: 66 women with bacterial vaginosis using intrauterin device were assigned to receive either 2% clindamycin vaginal cream or metronidazole vaginal tablet for 7 days.
💡
Sonuç & Katkı:Conclusion: Clindamycin 2% vaginal cream offers similar efficacy to vaginal metronidazole administration for treatment of bacterial vaginosis in women using intrauterin devices.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Klindamisin · Rahim içi araçlar · Metronidazol

Abstract

Objective: To examine the efficacy of clindamycin vaginal cream and vaginal metronadizole for the treatment of bacterial vaginosis in intrauterin device users. Study Design: 66 women with bacterial vaginosis using intrauterin device were assigned to receive either 2% clindamycin vaginal cream or metronidazole vaginal tablet for 7 days. Quantitative vaginal cultures for bacterial vaginosis were performed at enrollment and at 4-7 days and 30 days after completion of therapy. Results: Of the 66 patients using intrauterin device enrolled, 19 (61%) of 31 were cured with clindamycin, compared with 21 (60%) of 35 were cured with metronidazole at 30 days. No significant difference was observed between the treatment groups in the incidence of adverse events. Conclusion: Clindamycin 2% vaginal cream offers similar efficacy to vaginal metronidazole administration for treatment of bacterial vaginosis in women using intrauterin devices.

🔖

Bu Makaleye Atıf Yap

NESLİHANOĞLU, R., ÇALIŞKAN, A. C., AKPINAR, E., ALAGÖZ, A., BATIOĞLU, S., MOLLAMAHMUTOĞLU, L. (2005). Comparison of vaginal metronidazole with vaginal clindamycin for the treatment of bacterial vaginosis in women using intrauterine devices. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 11 - Sayı: 2, 107–109. https://ajindex.com/articles/227118

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Soper DE Bump RC, Hurt WG.Bacterial vaginosis and trichomoniasis vaginitis are risk factors for cuff cellulitis after abdominal hysterectomy. Am J Obstet Gynecol 1990
  2. Mead PB.Epidemiology of bacterial vaginosis. Am J Obstet Gynecol 1993
  3. Avonts D, Sercu M, Heyerick P.Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device:a prospective study. Sex Transm Dis 1990
  4. Watts DH, Krohn MA, Hillier SL, Eschenbach DA.Bacterial vaginosis as a risk factor for postcesarean endometritis. Obstet Gynecol 1990
  5. Eschenbach DA, Critchlow CW, Watkins H.A Dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis Suppl 1983
  6. Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H.Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993
  7. Spiegel CA, Amsel R, Eschenbach DA, Schoenknecht FD, Holmes KK.Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 1980
  8. 2000 red book drug topics. Montvale, NJ: Medical Economics Co
  9. 2000 9.Amsel R, Totten PA, Spiegel CA.Nonspecific vaginitis. Am J Med 1983
  10. 1O.Haukkamaa M, Stranden P, Jousimies-Somer H.Bacterial flora of the cervix in women using different methods of contraception. Am J Obstet Gynecol 1986
  11. Hillier S, Holmes KK.Bacterial vaginosis. In: Holmes KK, Mardh P, Sparling F, eds. Sexually transmitted diseases.2nd ed. New York: Me Graw Hill 1989:547-59. 12.Blackwell AL, Fox AR, Philips I, Barlow D.Anaerobic vaginosis: Clinical, microbiological and therapeutic findings. Lancet 1983:1379-82. 13.Livingood CH, Thomason JL, Hill GB.Bacterial va­ginosis: Treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990
  12. Hillier S, Krohn MA, Watts H, Wolner-Hanssen P, Eschenbach D.Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990
  13. Jorma Paavonen MD, Constantino Mangioni MD, Mau­reen A.Martin, Charles P.Wajszczuk MD.Vaginal clinda­mycin and oral metronidazole for bacterial vaginosis: A randomized trial. Obstet Gynecol 2000
  14. Joesoef MR, Schmid GP, Hillier SL.Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999
  15. Milani M, Barcellona E, Agnello A.Eff